510(k) · Cleared
ClearedCarrier XL Delivery Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Balt USA, LLC · QJP Catheter, Percutaneous, Neurovasculature
Cleared on Oct 22, 2025 as substantially equivalent to K230609 (Balt USA, LLC, 2023) after a 69-day review. Its family tree reaches back 7 generations to 1996.
- Decided
- Oct 22, 2025
- Review
- 69 days
- Class
- Class II
- Product code
- QJP
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 7 generations to K960806 (1996). 9 ancestors in all, the oldest K925813 (1994). No later device cites it as a predicate yet.
- Root · 7 generations backK960806 Turbo TrackerTarget Therapeutics · 1996
- 6 generations backK994155 Excelsior 1018 MicrocatheterBoston Scientific, Target · 2000
- 5 generations backK013789 Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189Boston Scientific, Target · 2001 · Recalled
- 4 generations backK083343 Headway 17 MicrocatheterMicroVention, Inc. · 2008
- 3 generations backK093160 Headway 21 Microcatheter, Model: MC212150SMicroVention, Inc. · 2009
- 2 generations backK172014 Wedge MicrocatheterMicroVention, Inc. · 2018
- 1 generation backK230609 NG Delivery CatheterBalt USA, LLC · 2023
- This deviceK252569 Carrier XL Delivery CatheterBalt USA, LLC · 2025
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −7 | K960806 | Turbo Tracker | Target Therapeutics | 1996 | — |
| −6 | K994155 | Excelsior 1018 Microcatheter | Boston Scientific, Target | 2000 | — |
| −5 | K013789 | Excelsior SL-10 Microcatheter, Models 168581, 168381, 168181, 168189 | Boston Scientific, Target | 2001 | 2 |
| −4 | K083343 | Headway 17 Microcatheter | MicroVention, Inc. | 2008 | — |
| −3 | K093160 | Headway 21 Microcatheter, Model: MC212150S | MicroVention, Inc. | 2009 | — |
| −2 | K172014 | Wedge Microcatheter | MicroVention, Inc. | 2018 | — |
| −1 | K230609 | NG Delivery Catheter | Balt USA, LLC | 2023 | — |
| 0 (this device) | K252569 | Carrier XL Delivery Catheter | Balt USA, LLC | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 1 | 0 |
| 2017 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QJP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QJP device
- #1 K212838 Benchmark Intracranial Access Systemscore 16.9 · 6 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K230609 | NG Delivery CatheterSummary page 5…Name: Percutaneous Catheter Device Classification: Class II Predicate Device: NG Delivery Catheter 510(k) #: K230609 Device Description: The Carrier XL Delivery Catheter is a single lumen, variable stiffness, composite catheter. The design facil… | 2023 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 29 years and passes through 4 companies; a new generation was cleared every 4.3 years on median.
- 1 of the 9 ancestors has a recall of any class.
How does its category compare?
All QJP devicesQJP Catheter, Percutaneous, Neurovasculature: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · QJP
22so far in 2026, the most since 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · QJP
116in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QJP
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QJP
688in 2025
MAUDE reports naming product code QJP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 9 | 72 | 0 | 16 |
| 2021 | 12 | 139 | 0 | 29 |
| 2022 | 14 | 206 | 0 | 30 |
| 2023 | 14 | 184 | 0 | 75 |
| 2024 | 18 | 188 | 1 | 130 |
| 2025 | 14 | 116 | 0 | 688 |
| 2026 | 22 | 141 | 0 | — |
What is it indicated for?
The Carrier XL Delivery Catheter is intended for general intravascular use, including the peripheral, coronary and neuro
vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional
devices, such as distal access catheters, in the neurovasculature.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K252569 · printed Nov 6, 2026
Cite this page
510(k) Report. “K252569: Carrier XL Delivery Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252569
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026